About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (20)
View allTotal Trials
20
As Lead Sponsor
20
As Collaborator
0
Total Enrollment
4,786
By Phase
PHASE2/PHASE3: 2PHASE1: 5PHASE2: 7PHASE3: 5
By Status
COMPLETED: 18WITHDRAWN: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline20 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05546359Lead Sponsor
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
PHASE2/PHASE3Completed
453 participants
Started: Jan 18, 2024 · Completed: Jun 3, 2025
NCT04954365Lead Sponsor
Post Operative Nausea and Vomiting (PONV) Rescue Outcomes After Amisulpride Treatment
N/AWithdrawn
Started: Nov 1, 2022 · Completed: Dec 31, 2024
NCT04851717Lead Sponsor
Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures
PHASE2/PHASE3Active, not recruiting
100 participants
Started: Nov 15, 2021 · Completed: Oct 31, 2027
NCT04849650Lead Sponsor
PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment
PHASE1Completed
12 participants
Started: Jun 3, 2021 · Completed: Oct 30, 2021
NCT04007406Lead Sponsor
DP13 - A Phase II Study in Patients With Primary Aldosteronism
PHASE2Completed
35 participants
Started: Nov 21, 2019 · Completed: May 2, 2022
Locations (1)
Headquarters
Cambridge, UK
Map
Loading map...